Granulomatous lung disease: clinical aspects
Amit Chopra1, Vaidehi Avadhani2, Anupama Tiwari1
1Department of Medicine, Pulmonary and Critical Care Medicine, Albany Medical Center , NY, USA.
Expert Review of Respiratory Medicine
|July 15, 2020
Summary
Distinguishing infectious from noninfectious granulomatous lung diseases (GLD) is crucial. This review outlines diagnostic approaches and proposes an algorithm to aid in differentiating these conditions, improving patient outcomes.
Area of Science:
- Pulmonology
- Pathology
- Infectious Diseases
Background:
- Granulomatous lung diseases (GLD) encompass diverse infectious and noninfectious etiologies.
- Accurate differentiation is critical to avoid misdiagnosis and ensure appropriate management.
- GLD classification impacts treatment strategies and patient prognosis.
Purpose of the Study:
- To review the clinical, histopathological, and diagnostic features of GLD.
- To propose a diagnostic algorithm for distinguishing infectious from noninfectious GLD.
- To enhance the understanding and management of granulomatous lung conditions.
Main Methods:
- Comprehensive literature search of PubMed and Medline databases (1950-2019).
- Inclusion of major GLDs such as mycobacterial and fungal infections, sarcoidosis, hypersensitivity pneumonitis, and vasculidities.
- Review of diagnostic criteria, microbiological techniques, and immunopathogenesis.
Main Results:
- Infectious GLD typically identified via microbiological culture and molecular methods.
- Noninfectious GLD often diagnosed using clinical/laboratory criteria with exclusion of infection.
- A proposed algorithm aids in differentiating infectious vs. noninfectious GLD.
Conclusions:
- Effective differentiation of infectious and noninfectious GLD is paramount for patient care.
- The proposed algorithm offers a structured approach to diagnosis.
- Further research into granulomatous response immunopathogenesis may refine diagnostic and therapeutic strategies.
Related Concept Videos
01:28Pulmonary Tuberculosis II
1.2K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.2K
01:20COPD: Pathogenesis and Clinical Features
1.7K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.7K
01:17Other Pulmonary Disorders
1.4K
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
1.4K
01:31Pulmonary Tuberculosis III
776
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
776
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
3.4K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.4K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.0K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.0K